Agenus | AGEN - Equity Capital And Reserves

Stock Price
3.01
Daily Change
-0.19 -5.94%
Monthly
2.38%
Yearly
28.09%
Q1 Forecast
3.23

Agenus reported $-274.14M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Agenus USD -274.14M 80.46M Sep/2025
Amgen USD 8.66B 961M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Celldex Therapeutics USD 527.16M 71.2M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Glaxosmithkline GBP 21.7B 7.35B Sep/2025
Incyte USD 5.17B 516.28M Dec/2025
Intrexon USD 43.17M 75.33M Jun/2024
J&J USD 78.47B 0 Sep/2025
Jiangsu Hengrui CNY 59.5B 814.63M Sep/2025
Karyopharm Therapeutics USD -269.26M 30.33M Sep/2025
MacroGenics USD 67M 20.38M Sep/2025
Merck EUR 28.94B 677M Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Northwest Biotherapeutics USD -108.65M 8.26M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Novavax USD -156.67M 194.3M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Rigel Pharmaceuticals USD 117.61M 35.67M Sep/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
Veracyte USD 1.26B 36.61M Sep/2025